We selected 5 peptide vaccines (TTK, URLC10, KOC1, VEGFR1 and VEGFR2) to overcome the immune-escape mechanisms and increase the therapeutic potential of the cancer vaccine. This evidence concerns the gene IGF2BP3 and cancer.